1,794
Views
23
CrossRef citations to date
0
Altmetric
Psychoanalytic Controversy

First do no harm

 

Notes

1 A reasonable estimate is that over 35% per cent of children referred are on the autism spectrum.

2 Serious concerns have been raised as to the long term effects on bone and brain developments, as well as on psychological development - see for example https://blogs.bmj.com/bmjebmspotlight/2019/02/25/gender-affirming-hormone-in-children-and-adolescents-evidence-review/

4 See for example Haider (Citation2018). Fraser N Rethinking Recognition, New Left Review May/June 2000.

5 I have written on this in a paper written at the time of the entry of the market form into the UK National Health System, which marked the beginning of the destruction of the welfare consensus; see Bell (Citation1997).

6 See Littman, https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0202330. The most explosive of Littman’s findings may be that among the young people reported on – 83 per cent of whom were designated female at birth – more than one-third had friendship groups in which 50 per cent or more of the youths began to identify as transgender in a similar time frame.

7 It is high time that the makers of puberty blockers were barred from providing support for conferences discussing gender dysphoria, given their direct interests in maintaining what has become a very lucrative market.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.